Anti Naked Shortselling Ein Erfolg wie bei GMXX? - 500 Beiträge pro Seite

[morchel]

Critical Home Care, Inc. Suspends DTC Transfer of its Stock
Due to Naked Short Selling Evidence

WESTBURY, N.Y., Dec. 17 /PRNewswire-FirstCall/ -- Critical Home Care, Inc.
("the Company") (BB:CCLH) announces the following information
regarding naked short selling of the Company`s common shares:

Effective December 17, 2002, the Company has become a "certificate only"
or "custody only" issuer requiring physical certification of Company ownership
for all share transfers. Furthermore, no valid or legally enforceable transfer
of CCLH stock can be made through Depository Trust Corporation ("DTC") and/or
Canadian Depository For Securities Limited ("CDS") or their nominees. DTC has
voluntarily cooperated with the Company to remove CCLH stock from electronic
eligibility. Upon listing on the American Stock Exchange, if approved, the
Company will reinstate its stock to DTC.
Naked short selling has increased in magnitude since the September 30,
2002 press release that noticed the public of the Company`s application to the
American Stock Exchange. The Company confirms the following facts:
As of the date of this press release no CRITICAL share options have been
exercised.
As at the date of this news release, the Company has issued and
outstanding common shares totaling 24, 442, 000 with only 5,750,000 free
trading common shares. The Company confirms that of the total 18,692,000
restricted shares issued, none have been, or are ineligible to be pledged,
borrowed, or hypothecated or used in any way for any normal short sale
coverage.

About Critical Home Care
Critical Home Care, Inc., markets, rents and sells surgical supplies, home
respiratory therapy products, orthotics and prosthetics, and durable medical
equipment, manufactured by third parties, primarily to individuals residing at
home. We also intend to provide pharmacy services in the future. In each line
of products and services, Critical Home Care, Inc. provides patients with a
variety of clinical services, related products and supplies, most of which are
prescribed by a physician as part of an overall plan of treatment. Serving
those living on Long Island and in the Five Boroughs of New York. Critical
Home Care, Inc. currently maintains six points of service having locations in
Rockville Centre, Westbury, Patchogue, Babylon, Woodbury and East Setauket,
New York. All clinicians are licensed where required by applicable law.
Additional information on Critical Home Care, Inc is available on the Internet
at http://www.CriticalHomeCare.com .

morchel

[loss_pro]

hab auch noch einen in der richtung heute:

ADVR Files Stock Manipulation Suit in Florida
Tuesday December 17, 2:55 pm ET

Complaint Claims Defendants Engaged in Activities to Intentionally Depress Share Price

YONKERS, N.Y., Dec. 17 /PRNewswire-FirstCall/ -- Advanced Viral Research Corp.
(OTC Bulletin Board: ADVR - News) today announced that it has filed suit in the Circuit
Court of the 11th Judicial Circuit of Florida charging that certain investors "misrepresented
their intentions in investing in the Company" and "engaged in a series of manipulative activities
to depress the price of Advanced Viral stock." The Company alleges that the defendants
sought to "guarantee they would be issued significantly more shares of ADVR common
stock" as a result of warrant repricing provisions of a September 2002 financing agreement.
The Company is seeking a judgement for damages, interest and costs.

The complaint names SDS Merchant
Fund, L.P., a Delaware limited
partnership; Alpha Capital, A.G.,
located in Vaduz, Lichtenstein; Knight
Securities, L.P., a limited partnership
conducting securities business in
Florida; Stonestreet Limited
Partnership located in Canada; and
Bristol Investment Fund, LTD., whose
principal place of business is in Grand
Cayman, Cayman Islands, among
others. The complaint claims that the
"defendants have each, at times acting
individually, and at times acting in
concert with at least one or more of
each other," engaged in practices that
violate sections of the Florida
Securities and Investor Protection Act.

"It is our contention that the defendants precipitated the drop in market price through their
manipulative activities, in an effort to take advantage of the warrant repricing provisions of
the financing agreement," said Eli Wilner, Chairman of the Board of Advanced Viral
Research Corp. "Following the execution of this financing agreement, our share price declined
from $0.18 to $0.06 per share. We are asking the Court to force the defendants to disgorge
the ill-gotten profits derived from their misconduct, including significant short selling and
dumping. We will aggressively pursue all legal remedies on behalf of the Company and its
shareholders."

Also named as a plaintiff in the case is William B. Bregman, a resident of Miami-Dade
County, Florida, and one of the largest shareholders of Advanced Viral. The complaint
contends that Mr. Bregman suffered losses of approximately $3.9 million as a result of the
stock manipulation scheme.

The suit is related to an agreement, announced September 9, 2002, pursuant to which the
Company issued and sold to certain investors 21,500,000 shares of its common stock, par
value $.00001 per share for total gross proceeds of $3,010,000, or $.14 per share. The
Company also issued warrants to purchase an aggregate of 16,125,002 shares of the
Company`s common stock, which were covered by provisions that allowed for an adjustment
of the warrant exercise price. The complaint charges the defendants with manipulating the
share price to take favorable advantage of these provisions.

Advanced Viral Research Corp., based in Yonkers, New York, is a biopharmaceutical firm
dedicated to improving patients` lives by researching, developing and bringing to market new
and effective therapies for viral and other diseases.

For further information regarding Advanced Viral Research Corp., please visit our website at
http://www.adviral.com.

Note: This news release contains forward-looking statements that involve risks associated
with clinical development, regulatory approvals, including application to the FDA, product
commercialization and other risks described from time to time in the SEC reports filed by the
Company. Product R is not approved by the U.S. Food and Drug Administration or any
comparable agencies of any other countries. There is no assurance that the Company will be
able to secure the financing necessary to continue and/or complete the clinical trials of
Product R or satisfy certain other conditions relating to clinical trials including obtaining
adequate insurance on terms acceptable to the Company. The Company undertakes no
obligation to update or revise the information contained in this announcement whether as a
result of new information, future events or circumstances or otherwise.



Source: Advanced Viral Research Corp.




na, weiß jemand warum ich die beiden shorties fettgedruckt habe????? schon mal gehört?

[loss_pro]

okay, ist ja schon gut, interessiert ja schließlich auch keinen:


Alpha Capital, A.G.,
located in Vaduz, Lichtenstein;

LAMP-finanzierung vom 1.11.2002



Bristol Investment Fund, LTD., whose
principal place of business is in Grand
Cayman, Cayman Islands

CALY-finanzierung von schlagmichtot2001



ps: warum hab ich bloß immer das gefühl, es müßte "morchel capital AG, lichtenstein" heißen...